Literature DB >> 3723497

Serum enzyme, myoglobin and muscle strength relationships in polymyositis and dermatomyositis.

M Kroll, J Otis, L Kagen.   

Abstract

Strength of the quadriceps and hamstring groups was biomechanically assessed in terms of isometric torque production in 14 patients with inflammatory myopathy. Eleven had polymyositis and 3, dermatomyositis. Determinations of serum creatine kinase, lactate dehydrogenase, transaminase, and myoglobin were simultaneously obtained over an average period of observation of 1.8 years. In certain individual patients, there were significant correlations between laboratory indices and strength during the entire course of illness. In others, this was not the case. In the total group of patients, absolute values of the laboratory indices did not correlate well with strength except in the case of serum myoglobin, where there a significant inverse relationship. Logarithmic transformations of the laboratory data increased the inverse correlations. High strength and low myoglobin were related to high prednisone dose. Since laboratory guides are not always related to disease activity, quantitative assessment of muscle strength is necessary.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3723497

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

1.  Inflammatory muscle disease assessment.

Authors:  Tim Y-T Lu; Kristine P Ng; David A Isenberg
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

Review 2.  Polymyositis-dermatomyositis: a clinical review.

Authors:  K W Strauss; H Gonzalez-Buritica; M A Khamashta; G R Hughes
Journal:  Postgrad Med J       Date:  1989-07       Impact factor: 2.401

3.  Correlation between tests of muscle involvement and clinical muscle weakness in polymyositis and dermatomyositis.

Authors:  K E Tymms; E M Beller; J Webb; L Schrieber; W W Buchanan
Journal:  Clin Rheumatol       Date:  1990-12       Impact factor: 2.980

Review 4.  Exercise in inflammatory myopathies, including inclusion body myositis.

Authors:  Helene Alexanderson
Journal:  Curr Rheumatol Rep       Date:  2012-06       Impact factor: 4.592

Review 5.  Laboratory evaluation of the inflammatory myopathies.

Authors:  L G Rider; F W Miller
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

Review 6.  The assessment and importance of disease activity versus disease damage in patients with inflammatory myopathy.

Authors:  Shabina M Sultan
Journal:  Curr Rheumatol Rep       Date:  2003-12       Impact factor: 4.592

7.  Soluble IL-2 receptor: a biomarker for assessing myositis activity.

Authors:  Anne Tournadre; Jean-Jacques Dubost; Martin Soubrier; Marc Ruivard; Pierre Souteyrand; Jeannot Schmidt; Pierre Clavelou; Arlette Tridon; Jean-Michel Ristori
Journal:  Dis Markers       Date:  2014-02-04       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.